These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 28796361)
1. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. McIver B; Grebe SKG; Wang L; Hay ID; Yokomizo ; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-757. PubMed ID: 28796361 [TBL] [Abstract][Full Text] [Related]
2. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880 [TBL] [Abstract][Full Text] [Related]
3. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528 [TBL] [Abstract][Full Text] [Related]
4. FHIT gene abnormalities in both benign and malignant thyroid tumours. Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301 [TBL] [Abstract][Full Text] [Related]
5. Aberrant transcripts of FHIT, TSG101 and PTEN/MMAC1 genes in normal peripheral mononuclear cells. Wang NM; Chang JG; Liu TC; Lin SF; Peng CT; Tsai FJ; Tsai CH Int J Oncol; 2000 Jan; 16(1):75-80. PubMed ID: 10601551 [TBL] [Abstract][Full Text] [Related]
6. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma. Mandai M; Konishi I; Kuroda H; Nanbu K; Matsushita K; Yura Y; Hamid AA; Mori T Eur J Cancer; 1998 Apr; 34(5):745-9. PubMed ID: 9713284 [TBL] [Abstract][Full Text] [Related]
7. Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers. Carney ME; Maxwell GL; Lancaster JM; Gumbs C; Marks J; Berchuck A; Futreal PA J Soc Gynecol Investig; 1998; 5(5):281-5. PubMed ID: 9773405 [TBL] [Abstract][Full Text] [Related]
8. Aberrant expression and deletion of FHIT gene in leukemias. Wang L; Dong LJ; Tian F; Liu GX; Li CH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):153-60. PubMed ID: 12744737 [TBL] [Abstract][Full Text] [Related]
9. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines]. Lee SH; Kim HS Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704 [TBL] [Abstract][Full Text] [Related]
10. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557 [TBL] [Abstract][Full Text] [Related]
11. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma. Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242 [TBL] [Abstract][Full Text] [Related]
13. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines. Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980 [TBL] [Abstract][Full Text] [Related]
15. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423 [TBL] [Abstract][Full Text] [Related]
16. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck. Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317 [TBL] [Abstract][Full Text] [Related]
18. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130 [TBL] [Abstract][Full Text] [Related]
19. Aberrant TSG101 transcripts in acute myeloid leukaemia. Lin PM; Liu TC; Chang JG; Chen TP; Lin SF Br J Haematol; 1998 Aug; 102(3):753-8. PubMed ID: 9722303 [TBL] [Abstract][Full Text] [Related]
20. Aberrant FHIT transcripts in human colorectal cancers. Lee SH; Lee SH Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]